Your browser doesn't support javascript.
loading
Prostate Cancer Lung Metastasis: Clinical Insights and Therapeutic Strategies.
Mahmoud, Ahmed M; Moustafa, Amr; Day, Carter; Ahmed, Mohamed E; Zeina, Wael; Marzouk, Usama M; Basourakos, Spyridon; Haloi, Rimki; Mahon, Mindie; Muniz, Miguel; Childs, Daniel S; Orme, Jacob J; Riaz, Irbaz Bin; Kendi, A Tuba; Stish, Bradley J; Davis, Brian J; Kwon, Eugene D; Andrews, Jack R.
Afiliación
  • Mahmoud AM; Department of Urology, Mayo Clinic, Rochester, MN 55905, USA.
  • Moustafa A; Department of Internal Medicine, The Brooklyn Hospital Center, Brooklyn, NY 11201, USA.
  • Day C; Department of Urology, Mayo Clinic, Rochester, MN 55905, USA.
  • Ahmed ME; Department of Urology, Mayo Clinic, Rochester, MN 55905, USA.
  • Zeina W; Department of Urology, Mayo Clinic, Rochester, MN 55905, USA.
  • Marzouk UM; Department of Internal Medicine, Ain Shams University, Cairo 11566, Egypt.
  • Basourakos S; Department of Urology, Mayo Clinic, Rochester, MN 55905, USA.
  • Haloi R; Department of Urology, Mayo Clinic, Rochester, MN 55905, USA.
  • Mahon M; Department of Urology, Mayo Clinic, Rochester, MN 55905, USA.
  • Muniz M; Department of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.
  • Childs DS; Department of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.
  • Orme JJ; Department of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.
  • Riaz IB; Department of Medical Oncology, Mayo Clinic, Scottsdale, AZ 85259, USA.
  • Kendi AT; Department of Radiology, Division of Nuclear Medicine, Mayo Clinic, Rochester, MN 55905, USA.
  • Stish BJ; Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA.
  • Davis BJ; Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA.
  • Kwon ED; Department of Urology, Mayo Clinic, Rochester, MN 55905, USA.
  • Andrews JR; Department of Urology, Mayo Clinic, Phoenix, AZ 85054, USA.
Cancers (Basel) ; 16(11)2024 May 30.
Article en En | MEDLINE | ID: mdl-38893199
ABSTRACT
Prostate cancer lung metastasis represents a clinical conundrum due to its implications for advanced disease progression and the complexities it introduces in treatment planning. As the disease progresses to distant sites such as the lung, the clinical management becomes increasingly intricate, requiring tailored therapeutic strategies to address the unique characteristics of metastatic lesions. This review seeks to synthesize the current state of knowledge surrounding prostate cancer metastasis to the lung, shedding light on the diverse array of clinical presentations encountered, ranging from subtle radiological findings to overt symptomatic manifestations. By examining the diagnostic modalities utilized in identifying this metastasis, including advanced imaging techniques and histopathological analyses, this review aims to provide insights into the diagnostic landscape and the challenges associated with accurately characterizing lung metastatic lesions in prostate cancer patients. Moreover, this review delves into the nuances of therapeutic interventions employed in managing prostate cancer lung metastasis, encompassing systemic treatments such as hormonal therapies and chemotherapy, as well as metastasis-directed therapies including surgery and radiotherapy.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos